Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AcelRx Pharmaceuticals, Inc. (ACRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.2192+0.0112 (+5.38%)
At close: 04:00PM EDT
0.2492 +0.03 (+13.69%)
After hours: 07:59PM EDT
Advertisement
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
No. of Analysts2222
Avg. Estimate-0.07-0.06-0.23-0.14
Low Estimate-0.09-0.07-0.26-0.15
High Estimate-0.06-0.06-0.21-0.14
Year Ago EPS-0.08-0.07-0.29-0.23
Revenue EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
No. of Analysts2222
Avg. Estimate550k770k7.15M23.4M
Low Estimate500k700k3.3M22.4M
High Estimate600k850k10.99M24.41M
Year Ago Sales1.81MN/A2.82M7.15M
Sales Growth (year/est)-69.60%N/A153.70%227.30%
Earnings History6/29/20219/29/202112/30/20213/30/2022
EPS Est.-0.08-0.07-0.07-0.06
EPS Actual-0.08-0.07-0.06-0.06
Difference000.010
Surprise %0.00%0.00%14.30%0.00%
EPS TrendCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
Current Estimate-0.07-0.06-0.23-0.14
7 Days Ago-0.07-0.06-0.23-0.14
30 Days Ago-0.07-0.06-0.23-0.14
60 Days Ago-0.06-0.06-0.22-0.16
90 Days Ago-0.06-0.06-0.22-0.16
EPS RevisionsCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACRXIndustrySector(s)S&P 500
Current Qtr.12.50%N/AN/AN/A
Next Qtr.14.30%N/AN/AN/A
Current Year20.70%N/AN/AN/A
Next Year39.10%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A
Advertisement
Advertisement